Photo of Agnes G. Horvath, MD

Agnes G. Horvath, MD

Accepting New Patients
1201 West La Veta Avenue
Orange, CA 92868
1962.1 miles away
Speaks: English
map

CHOC Children's Specialists - Hematology Oncology

1201 West La Veta Avenue, Orange, CA 92868

Are you covered?

Check to see if your insurance is covered by this provider.

About Agnes G. Horvath

Dr. Agnes Horvath is a pediatric hematology/oncology with CHOC Children’s Specialists. Dr. Horvath has been featured in various publications regarding treatment of leukemia in children. She has done collaborative research work on stem cell biology as a visiting investigator. Dr. Horvath is affiliated with the Institute of Functional Medicine. Prior to joining CHOC Children’s Dr. Horvath attended medical school at Semmelweiss Medical School in Budapest, Hungary. He served her residency trainings in pediatrics at Hematology University Pediatric Clinic in Budapest and University of East Carolina Medical Center in Greenville, North Carolina. Dr. Hawthorne completed fellowship training in pediatric hematology/oncology at St. Jude Children’s Research Hospital in Memphis, Tennessee and Memorial Sloan Kettering Cancer Center in New York. Dr. Horvath is board certified in three specialties: pediatrics, pediatric hematology/oncology, and hospice and palliative medicine, giving her a combination of expertise not seen at many other hospitals. She puts this training to use as the medical director and founder of the CHOC Children’s supportive care program, which focuses solely on supporting patients and families outside of traditional medical care. Supportive care does not replace the medical care patients receive at CHOC, but it is offered alongside it. That includes helping manage symptoms, cope with feelings and minimize discomfort. “Research shows that patients who receive supportive care are more likely to live longer and have a better quality of life, with less suffering,” Dr. Horvath says. Supportive care that includes complementary and alternative medicine is rarely available at children’s hospitals, making CHOC truly unique. Her goals for the supportive care program at CHOC are to establish communication, continuity of care, trust and respect with families. “We want to provide global, supportive care for every need,” she says. “We work with our children and parents during decision-making. We help them set goals and listen to their values, and we respect their hopes.”

Board Certifications
  • American Board of Pediatrics, Pediatric Hematology-Oncology
  • American Board of Pediatrics, Pediatrics

Clinical Interests

  • Adverse Effects To Anticoagulants
  • Anemia
  • Bleeding Disorder
  • Blood Cancer
  • Blood Disorders
  • Bone Marrow Disorders
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer Pain
  • Cancer Related Fatigue
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Clinical Trials
  • Colorectal Cancer
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Hellp Syndrome
  • Hematologic Malignancies
  • Hemoglobinopathies
  • Idiopathic Thrombocytopenic Purpura
  • Iron Deficiency Anemia
  • Leukopenia
  • Lung Cancer
  • Lymphedema Therapy
  • Lymphoma
  • Lymphopenia
  • Melanoma
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Metastatic Liver Cancer
  • Metastatic Prostate Cancer
  • Musculoskeletal Tumor
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Neutropenia
  • Non Hodgkin Lymphoma
  • Oral Complications Of Cancer
  • Osteosarcoma
  • Pancytopenia
  • Petechiae
  • Polycythemia
  • Pulmonary Metastases
  • Retroperitoneal Mass
  • Sarcoma
  • Secondary Polycythemia
  • Side Effects Of Cancer Treatment
  • Splenomegaly
  • Squamous Cell Carcinoma Of The Head And Neck
  • Stomach Cancer
  • Submucosal Tumors
  • Sweat Gland Carcinoma
  • Targeted Molecular Therapy
  • Thalassemia
  • Thoracic Cancer
  • Thrombocytopenia
  • Thrombophilia
  • Thyroid Cancer
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Von Willebrand Disease
  • Waldenstrom Macroglobulinemia